TNGX Tango Therapeutics Inc: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik tangotx.com (TNGX)

The enterprise value assessment via EV/Sales demonstrates the asset's dynamics, where the 0.00 mark serves as a key metric. Tango Therapeutics (TNGX) is implementing robots for accelerated molecule screening. Manufacturing processes have been outsourced to external plants to ensure stability. Meanwhile, the company adheres to ESG standards by optimizing biomaterial recycling and reagent logistics.

Nilai perusahaan marang pendapatan: Tango Therapeutics Inc (TNGX) kanggo 23.11.2025 - 20.11.2026

tangotx.com - rincian analitis lan metrik utama (TNGX)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:Tango Therapeutics TNGX
Sampel barang Tango Therapeutics

Tango Therapeutics (TNGX) develops advanced oncology drugs currently in clinical trials. This indicator excludes the impact of leverage, measuring the enterprise value through the lens of generated revenue. By analyzing the enterprise value-to-revenue ratio, one can identify unjustified price spikes or undervalued assets. For a company with an emerging product life cycle, this serves as a critical filter against overpayment. Extreme values of this metric signal either inflated expectations or the risk of capital stagnation.

Analisis pesaing Tango Therapeutics

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan IOVA (Iovance)|Koefisien nilai perusahaan marang pendapatan IMTX|Multiplikator EV/Sales XNCR (Xencor)|Nilai bisnis marang pendapatan CMPX|replimune.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Lyell Pharma|Innate Pharma S.A. (IPHA) - Rasio nilai perusahaan marang pendapatan|Pyxis Oncology Inc. - Nilai bisnis marang pendapatan|CGEN (Compugen Limited) - Multiplikator EV/Sales|Multiplikator EV/Sales IO Biotech Inc|Rasio nilai perusahaan marang pendapatan Sutro Biopharma (STRO)|INKT: Nilai perusahaan marang volume dodolan|Werewolf Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Immix (IMMX) - Multiplikator nilai perusahaan marang pendapatan|ALX Oncology Holdings Inc. - Multiplikator EV/Sales|CUE - Multiplikator EV/Sales|PDSB: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings Inc. (SONN)|MAIA (MAIABiotech.com) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Liminatus Pharma (LIMN)|Multiplikator EV/Sales LVTX|Koefisien nilai perusahaan marang pendapatan NXTC|Leap Therapeutics, Inc. - Nilai perusahaan marang pendapatan|INTS: Rasio nilai perusahaan marang pendapatan|Sensei Biotherapeutics Inc - Multiplikator EV/Sales|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP